feed,title,long_url,short_url
Benzinga,"FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca",https://benzinga.com/general/biotech/23/11/35822094/fda-approves-bristol-myers-lung-cancer-drug-acquired-via-4b-turning-point-deal-competes-with-roch,https://da.gd/Cf4DRd
